Furthermore, the main role of GLP-1 is to modulate bile acid signaling through the farnesoid X receptor (FXR), which can modify the gut microbiome and promote NAFLD [78]. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.